日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Impact of Germline BRCA Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis

生殖系 BRCA 突变状态对改良 FOLFIRINOX 方案治疗晚期胰腺癌患者抗肿瘤活性的影响：一项探索性分析

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO-25-01104
Lee, Lingaku; Tachibana, Yuichi; Matsuo, Susumu; Niina, Yusuke; Fujiyama, Takashi; Hisano, Terumasa; Sugimoto, Rie; Akashi, Tetsuro; Ogoshi, Keiichiro; Furukawa, Masayuki
胰腺癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Gemcitabine + Cisplatin + S-1 Treatment for Advanced Cholangiocarcinoma: Cost-Effective, with Better Progression-Free Survival Versus Standard Treatment with Gemcitabine + Cisplatin + Durvalumab

吉西他滨+顺铂+S-1方案治疗晚期胆管癌：与吉西他滨+顺铂+度伐利尤单抗标准治疗相比，该方案更具成本效益，且无进展生存期更长

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17243971
Morita, Yusuke; Sugimoto, Rie; Kurokawa, Miho; Tanaka, Yuki; Senju, Takeshi; Ichimaru, Toshimitsu; Lee, Lingaku; Niina, Yusuke; Hisano, Terumasa; Furukawa, Masayuki; Sugimachi, Keishi; Tanaka, Masatake
肿瘤
胆管癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Zinc Deficiency as a General Feature of Cancer: a Review of the Literature

锌缺乏作为癌症的普遍特征：文献综述

期刊:Biological Trace Element Research
影响因子:3.6
doi:10.1007/s12011-023-03818-6
Sugimoto, Rie; Lee, Lingaku; Tanaka, Yuki; Morita, Yusuke; Hijioka, Masayuki; Hisano, Terumasa; Furukawa, Masayuki
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B

尼拉帕尼治疗 BRCA 突变型胆道癌、胰腺癌及其他胃肠道癌症的 II 期临床试验：NIR-B

期刊:Future Oncology
影响因子:2.6
doi:10.2217/fon-2023-0348
Kawamoto, Yasuyuki; Morizane, Chigusa; Komatsu, Yoshito; Kondo, Shunsuke; Ueno, Makoto; Kobayashi, Satoshi; Furukawa, Masayuki; Lee, Lingaku; Satoh, Taroh; Sakai, Daisuke; Ikeda, Masafumi; Imaoka, Hiroshi; Miura, Arisa; Hatanaka, Yutaka; Yokota, Isao; Nakamura, Yoshiaki; Yoshino, Takayuki
胰腺癌
肿瘤
胆管癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Cofilin activation in pancreatic acinar cells plays a pivotal convergent role for mediating CCK-stimulated enzyme secretion and growth

胰腺腺泡细胞中的肌动蛋白丝切蛋白激活在介导 CCK 刺激的酶分泌和生长中起着关键的聚合作用

期刊:Frontiers in Physiology
影响因子:3.2
doi:10.3389/fphys.2023.1147572
Irene Ramos-Alvarez, Lingaku Lee, Robert T Jensen
细胞生物学
其它细胞
FCM
IF
IHC-P
WB
COF1
发表日期：2023
文献求助 收藏

Serum zinc levels in cancer patients are low and difficult to elevate when complicated by liver cirrhosis: A retrospective study

癌症患者血清锌水平低，且合并肝硬化时难以升高：一项回顾性研究

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000032703
Sugimoto, Rie; Tanaka, Yuki; Senju, Takeshi; Morita, Yusuke; Lee, Lingaku; Hijioka, Masayuki; Hisano, Terumasa; Furukawa, Masayuki
肿瘤
肝硬化
肿瘤免疫
发表日期：2023
文献求助 收藏

Liver metastasis composed of pure squamous cell carcinoma component from pancreatic pure ductal adenocarcinoma: a case report

胰腺纯导管腺癌肝转移灶由纯鳞状细胞癌成分构成：病例报告

期刊:Surgical Case Reports
影响因子:0.7
doi:10.1186/s40792-023-01755-z
Mano, Yohei; Sugimachi, Keishi; Shimagaki, Tomonari; Tomino, Takahiro; Onishi, Emi; Lee, Lingaku; Hisano, Terumasa; Koga, Yutaka; Taguchi, Kenichi; Morita, Masaru; Toh, Yasushi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies

晚期胰腺神经内分泌肿瘤患者对药物/放射/肝脏靶向抗肿瘤治疗产生耐药性的预测因素：最新进展与争议

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14051250
Lee, Lingaku; Ramos-Alvarez, Irene; Jensen, Robert T
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study

吉西他滨治疗后，纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸治疗晚期胰腺癌患者的疗效和安全性：一项多中心前瞻性观察研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm11175084
Miki, Masami; Fujimori, Nao; Ueda, Keijiro; Lee, Lingaku; Murakami, Masatoshi; Takamatsu, Yu; Shimokawa, Yuzo; Niina, Yusuke; Oono, Takamasa; Hisano, Terumasa; Furukawa, Masayuki; Ogawa, Yoshihiro
胰腺癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse survival after second-line therapy of advanced pancreatic cancer

一线吉西他滨/白蛋白紫杉醇治疗期间发生的脂肪组织或骨骼肌丢失与晚期胰腺癌二线治疗后生存率降低相关。

期刊:Asia-Pacific Journal of Clinical Oncology
影响因子:1.6
doi:10.1111/ajco.13669
Miki, Masami; Lee, Lingaku; Hisano, Terumasa; Sugimoto, Rie; Furukawa, Masayuki
胰腺癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏